NR4A2
Nuclear receptor subfamily 4 group A member 2
Also known as: HZF-3, NOT, NR4A2_HUMAN, NURR1, RNR1, TINUR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P43354
- Gene
- NR4A2
- Ensembl
- ENSG00000153234
- Chromosome
- 2
- Canonical length
- 598 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. The encoded protein may act as a transcription factor. Mutations in this gene have been associated with disorders related to dopaminergic dysfunction, including Parkinson disease, schizophernia, and manic depression. Misregulation of this gene may be associated with rheumatoid arthritis. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
598 residues, UniProt reviewed canonical sequence.
>P43354|NR4A2
1 MPCVQAQYGS SPQGASPASQ SYSYHSSGEY SSDFLTPEFV KFSMDLTNTE ITATTSLPSF
61 STFMDNYSTG YDVKPPCLYQ MPLSGQQSSI KVEDIQMHNY QQHSHLPPQS EEMMPHSGSV
121 YYKPSSPPTP TTPGFQVQHS PMWDDPGSLH NFHQNYVATT HMIEQRKTPV SRLSLFSFKQ
181 SPPGTPVSSC QMRFDGPLHV PMNPEPAGSH HVVDGQTFAV PNPIRKPASM GFPGLQIGHA
241 SQLLDTQVPS PPSRGSPSNE GLCAVCGDNA ACQHYGVRTC EGCKGFFKRT VQKNAKYVCL
301 ANKNCPVDKR RRNRCQYCRF QKCLAVGMVK EVVRTDSLKG RRGRLPSKPK SPQEPSPPSP
361 PVSLISALVR AHVDSNPAMT SLDYSRFQAN PDYQMSGDDT QHIQQFYDLL TGSMEIIRGW
421 AEKIPGFADL PKADQDLLFE SAFLELFVLR LAYRSNPVEG KLIFCNGVVL HRLQCVRGFG
481 EWIDSIVEFS SNLQNMNIDI SAFSCIAALA MVTERHGLKE PKRVEELQNK IVNCLKDHVT
541 FNNGGLNRPN YLSKLLGKLP ELRTLCTQGL QRIFYLKLED LVPPPAIIDK LFLDTLPFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR4A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 126 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 126 nTPM
- adrenal gland: 125 nTPM
- ovary: 122 nTPM
- blood vessel: 52 nTPM
- pituitary gland: 51 nTPM
- urinary bladder: 50 nTPM
Single-cell type
- mast cells: 794 nCPM
- endometrial luminal cells: 698 nCPM
- cdc: 694 nCPM
- monocytes: 675 nCPM
- macrophages: 524 nCPM
- nk-cells: 506 nCPM
Immune cell
- neutrophil: 6 nTPM
- eosinophil: 2.3 nTPM
- basophil: 2 nTPM
- myeloid DC: 1.9 nTPM
- classical monocyte: 1.5 nTPM
- gdT-cell: 0.9 nTPM
Brain region
- cerebral cortex: 97 nTPM
- cerebellum: 78 nTPM
- midbrain: 27 nTPM
- hippocampal formation: 21 nTPM
- choroid plexus: 21 nTPM
- white matter: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NR4A2.
Disease | AllUniProt
Conditions NR4A2 is implicated in, by any mechanism.
- Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism (IDLDP) MIM:619911
Disease | GeneticClinVar
52 pathogenic / likely-pathogenic of 251 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism
- Inborn genetic diseases
- Epilepsy
- Neurodevelopmental disorder
- Autism spectrum disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adult locomotory behavior
- canonical Wnt signaling pathway
- cellular response to corticotropin-releasing hormone stimulus
- cellular response to oxidative stress
- central nervous system neuron differentiation
- central nervous system projection neuron axonogenesis
- DNA-templated transcription
- dopamine biosynthetic process
- dopaminergic neuron differentiation
- fat cell differentiation
- habenula development
- midbrain dopaminergic neuron differentiation
- negative regulation of apoptotic signaling pathway
- negative regulation of neuron apoptotic process
- negative regulation of transcription by RNA polymerase II
- neuron apoptotic process
- neuron maturation
- neuron migration
- positive regulation of transcription by RNA polymerase II
- post-embryonic development
- regulation of dopamine metabolic process
- regulation of respiratory gaseous exchange
- regulation of transcription by RNA polymerase II
- response to amphetamine
- response to hypoxia
- transcription by RNA polymerase II
- general adaptation syndrome
Molecular functions
- beta-catenin binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- nuclear glucocorticoid receptor binding
- nuclear receptor activity
- nuclear retinoid X receptor binding
- protein heterodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Nuclear receptor subfamily 4 group A member 1-3
- Zinc finger, NHR/GATA-type
- Nuclear hormone receptor-like domain superfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
- Nuclear receptor subfamily 4 group A member 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NR4A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR4A2 as an antibody target. Whether an autoantibody or antibody against NR4A2 could matter depends on whether native NR4A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR4A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR4A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...